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Transcription-replication conflicts lead to DNA damage and genomic instability, which are closely related to human diseases. A
major source of these conflicts is the formation of R-loops, which consist of an RNA-DNA hybrid and a displaced single-stranded
DNA. Although these structures have been studied, many aspects of R-loop biology and R-loop-mediated genome instability
remain unclear. Here, we demonstrate that thyroid hormone receptor-associated protein 3 (Thrap3) plays a critical role in regulating
R-loop resolution. In cancer cells, Thrap3 interacts with DEAD-box helicase 5 (DDX5) and localizes to R-loops. Arginine-mediated
methylation of DDX5 is required for its interaction with Thrap3, and the Thrap3-DDX5 axis induces the recruitment of 5’-3’
exoribonuclease 2 (XRN2) into R-loops. Loss of Thrap3 increases R-loop accumulation and DNA damage. These findings suggest that
Thrap3 mediates resistance to cell death by preventing R-loop accumulation in cancer cells.
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INTRODUCTION
R-loops are three-stranded nucleic acid structures consisting of a
cotranscriptionally generated RNA-DNA hybrid and a displaced
single-stranded DNA1–4. They have critical roles in a wide range of
eukaryotic metabolic processes, such as chromosome segregation
during mitosis, immunoglobulin class switching, DNA replication
and repair, and transcription initiation/termination3–5. In addition,
R-loops are involved in gene expression and rearrangement;6
however, they also threaten genome integrity, resulting in
deleterious cellular effects. For example, abnormal accumulation of
R-loops and subsequent collisions with replication forks is followed
by DNA damage and genome instability1,4,6,7. R-loops have been
postulated to be causative factors for many human diseases, such as
neurodegenerative diseases, cancer, and autoimmune diseases2.
Thus, proper regulation of R-loops in cells is essential.
DEAD-box helicase 5 (DDX5) is a critical factor in R-loop
resolution; it associates with 5’-3’ exoribonuclease 2 (XRN2) and
resolves R-loops at transcription sites8,9. DDX5 depletion leads to
R-loop accumulation at these loci. Protein arginine methyltrans-
ferase 5 (PRMT5) binds to DDX5 and methylates it specifically at its
RGG/RG motif8,9. This motif is required for the interaction of DDX5
with XRN2 and for the repression of cellular R-loop formation but
is not essential for the enzymatic helicase activity of DDX58,9.
However, the factors involved in this mechanism of R-loop
resolution are still not known.
In eukaryotic cells, pre-mRNA splicing and postsplicing events
following transcription are essential for efficient gene expres-
sion10. Many proteins are involved in multiple stages of pre-mRNA
processing, and these factors are components of the ribonucleo-
protein complex called the spliceosome10. The nuclear protein
Thrap3 (thyroid hormone receptor-associated protein 3) is an
important component of the spliceosome in nuclear speckles and
is a transcriptional coregulator11. Structurally, Thrap3 shares a
homologous amino acid sequence with Bcl2-associated transcrip-
tion factor 1 (BCLAF1) and contains arginine-serine rich domains,
which are conserved features of the RNA splicing protein
family12,13. Moreover, Thrap3 depletion causes cellular hypersen-
sitivity to DNA-damaging agents12. Thus, Thrap3 is potentially
involved in nuclear RNA transcription, processing, and metabo-
lism, as well as in the maintenance of genomic stability.
In this study, we explored the role of Thrap3 in R-loop-
associated DNA damage. We found that Thrap3 interacts with
DDX5 and that this interaction is followed by XRN2 recruitment for
R-loop resolution. Thrap3 specifically binds to arginine methy-
lated-DDX5, suggesting that Thrap3 mediates resistance to DNA
damage by preventing R-loop accumulation in oncogenic cells.
MATERIALS AND METHODS
Cell culture
U2OS cells, MCF7 cells, HEK-293T cells, and MEFs (mouse embryonic
fibroblasts) were obtained from the American Type Culture Collection (ATCC,
Manassas, VA, USA) and cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS). To analyze the
proliferation ability of MCF7 cells, 104 cells were seeded in a 24-well plate,
and the cell number was monitored using an IncuCyte FLR cell imaging
microscope (Essen Bioscience, Ann Arbor, MI, USA) every day. Knockdown of
Thrap3 in MCF7 cells was performed using lentiviral shRNA transduction. For
lentivirus production, HEK-293T cells were transfected with lentiviral
pLKO.1 shRNA plasmids (Sigma Aldrich, St. Louis, MO, USA) together with
packaging and envelope plasmids. Culture media from transfected cells were
collected and applied into MCF7 cells. Following infection, cells were selected
with puromycin (VWR Chemicals, Radnor, PA, USA).
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Fig. 1 Thrap3 colocalizes with R-loops, and Thrap3 depletion leads to accumulation of R-loops. a U2OS cells were transfected with
scrambled (control) or Thrap3-targeted (Thrap3) siRNA for 24 h. The cells were then subjected to a PLA to assess the physical closeness of
Thrap3 and R-loops. (Left) representative images are shown; (right) percentages of PLA signal-positive nuclei were calculated from at least 30
cells. Mean ± SEM; n= 4; ****P < 0.0001. The scale bar represents 1 μm. b DRIP was performed, and the precipitates were analyzed by
immunoblotting for Thrap3 and PCNA. (Left) Schematic of DNA-RNA hybrid immunoprecipitation (DRIP) assay. c U2OS cells were transfected
with scrambled siRNA (control) or Thrap3-targeted (Thrap3) siRNA for 48 h. Cells were fixed and immunostained for S9.6 and nucleolin. (Top)
representative images. (Bottom) the number of S9.6 foci per nucleus after subtraction of nucleolar signals was determined from at least 50
nuclei. Mean ± SEM, ****P < 0.0001. The scale bar represents 1 μm. d U2OS cells were transfected with empty vector (Control) and Thrap3
expression plasmids (Thrap3) for 48 h. Cells were fixed and immunostained for S9.6 and nucleolin. (Left) representative images. (Right) the
number of S9.6 foci per nucleus was determined from at least 50 nuclei. Mean ± SEM, ****P < 0.0001. The scale bar represents 1 μm.
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Plasmids and siRNAs
The V5-tagged RNaseH1 (Cat# 111906) plasmid was purchased from
Addgene (Watertown, MA, USA), and the Flag/Myc-tagged DDX5 plasmid
was provided by the Center for Genomic Integrity (CGI) at UNIST. The
FLAG/Myc-tagged Thrap3 plasmid was purchased from Origene (Rockville,
MD, USA). Plasmids containing HA-tagged full-length and truncated
Thrap3 were kindly provided by Woan-Yuh Tarn, National Taiwan
University, Taipei, Taiwan. The sequences of the siRNAs were 5′-UUC
UCC GAA CGU GUC ACG UTT-3′ for the control and 5′-GGU AUA AGC UCC
GAG AUG A-3′ for human Thrap3. Transfection of the RNaseH1-V5, Flag/
Myc-DDX5, and HA-Thrap3 plasmids and siRNAs was conducted with
Lipofectamine 2000 and RNAiMAX transfection reagent (Invitrogen,
Carlsbad, CA, USA), respectively. The transfection protocol was performed
according to the manufacturer’s instructions.
Cell lysis, western blotting, and immunoprecipitation
Whole-cell lysates were prepared by treating cold PBS-washed cells with
RIPA lysis buffer mixed with 1% sodium deoxycholate, protease inhibitors
(Roche, Basel, Switzerland), and phosphatase inhibitor cocktail (Sigma
Aldrich, St. Louis, MO, USA). Collected protein extracts were quantified with
a Pierce BCA Protein Assay Kit. Equal amounts of protein were loaded onto
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SDS–PAGE gels and transferred to a nitrocellulose membrane (GE
Healthcare, Chicago, IL, USA). The membrane was blocked with 5% skim
milk and incubated with each primary antibody overnight. Proteins were
detected with chemiluminescent HRP substrate solutions (Advansta, Bering
Drive San Jose, CA, USA). For immunoprecipitation, cleared cell extracts
were incubated with specific antibodies overnight. Then, the protein-
antibody samples were mixed with protein A/G agarose beads for 2 h and
precipitated. Proteins were analyzed by blotting with antibodies specific
for the following molecules: Thrap3 (F-10) (Santa Cruz Biotechnology, Cat#
sc-133250), DNA-RNA Hybrid [S9.6] (Kerafast, Cat# ENH001), PCNA (PC10)
(Santa Cruz Biotechnology, Cat# sc-56), DDX5 (A-5) (Santa Cruz Biotechnol-
ogy, Cat# sc-166167), XRN2 (LifeSpan Bioscience, Cat# LS-B14272), mono-
and dimethyl arginine (Abcam, Cat# ab412), β-Actin (Sigma–Aldrich, Cat#
A5441), FLAG (Sigma–Aldrich, Cat# F7425), and HA-Peroxidase (3F10)
(Roche, Cat# 12013819001).
Immunofluorescence
U2OS cells were seeded on chamber slides. A day after seeding, cells were
washed twice with PBS and permeabilized with 0.5% Triton X-100 for 5 min
on ice before fixation with 4% paraformaldehyde for 15min at RT. After
washing with PBS, 0.5% Triton X-100 was added to permeabilize the cells.
For chromatin-bound protein analysis, this series of steps was altered as
follows: permeabilization with 0.5% Triton X-100 for 2 min and fixation with
100% methanol for 30min. Then, cells were treated with blocking buffer
for 1 h and incubated with primary antibodies overnight. After washing,
cells were incubated with Alexa Fluor-conjugated secondary antibodies for
1 h. PBS-washed cells were visualized with a fluorescence microscopic
imaging system. Antibodies against S9.6 (Kerafast, Cat # ENH001),
Nucleolin (Cell Signaling Technologies, Cat# 14574), γH2AX (Millipore,
Cat# 05–636), and 53BP1 (Cell Signaling Technologies, Cat# 4937)
were used.
Proximity ligation assay
The proximity ligation assay was carried out using a Duolink ≌ ® PLA
fluorescence kit (Sigma Aldrich, St. Louis, MO, USA) with the standard
protocols described as follows. Briefly, after the extraction, fixation, and
permeabilization steps for slide-seeded U2OS cells, cells were blocked with
2% BSA in PBS for 1 h. Cells were incubated with primary antibodies and
washed with PBS. Then, cells were incubated with premixed PLUS and
MINUS PLA probes for 1 h. Samples were incubated with fluorescent
ligation solution and amplification solution for 30min and 100min each,
respectively. After a final wash, slides were mounted with DAPI and
analyzed with a confocal microscope using a ×63 oil immersion objective.
The numbers of nuclear PLA foci were quantified in the acquired images.
DRIP (S9.6 DNA:RNA immunoprecipitation) assay
Cells were incubated with lysis buffer containing 85mM KCl, 5 mM PIPES
(pH 8.0), and 0.5% NP-40 for 10min. Lysed cells were collected and
centrifuged for 5 min at 3000 × g. The pellet (nuclei) was resuspended in
RSB buffer (10mM Tris-HCl (pH 7.5), 200 mM NaCl, and 2.5 mM MgCl2) with
0.2% sodium deoxycholate, 0.1% SDS, 0.5% Triton X-100, and protease
inhibitor cocktail. Nuclei were sonicated for 10min using a Diagenode
Bioruptor. Then, the extracts were diluted in RSB buffer with 0.5% Triton
X-100 and subjected to immunoprecipitation with the S9.6 antibody.
EdU-incorporation assay for DNA replication
DNA replication was assessed by detecting EdU (5-ethynyl-2′-deoxyuridine)
incorporation using a Click-iT™ EdU Cell Proliferation Kit (Invitrogen,
Carlsbad, CA, USA) and Alexa Fluor™ 488 dye. Thrap3 knockdown and/or
RNaseH1-overexpressing U2OS cells were labeled with EdU working
solution for 15min. After incubation, the medium was immediately
removed, and the cells were fixed with 4% formaldehyde in PBS for 15min
and permeabilized with 0.5% Triton X-100 in PBS for 20min. The
permeabilization buffer was removed from the cells, and Click-iT™ reaction
cocktail containing CuSO4 and Alexa Fluor azide solution in reaction buffer
was added to the cells for 30min. For nuclear visualization, DAPI was
added. EdU-incorporation was detected with a fluorescence microscope,
and the number of EdU-positive cells and the fluorescence intensity were
analyzed.
Purification and mass spectrometry analysis
HEK293 cells were transfected with the FLAG/Myc-tagged Thrap3 plasmid
for ectopic expression of Thrap3, and lysates were incubated with anti-
FLAG M2 agarose (Sigma Aldrich, St. Louis, MO, USA). After incubation,
FLAG-tagged Thrap3 and interacting proteins were washed and eluted
with 3X FLAG peptide (Sigma Aldrich, St. Louis, MO, USA). The eluted
proteins were separated by SDS–PAGE, and the molecular characterization
was analyzed through reversed-phase LC–MS/MS using an LTQ-Orbitrap
high-resolution hybrid mass spectrometer (Thermo Fisher Scientific,
Waltham, MA, USA).
Statistical analysis
All data are presented as the mean ± standard error of the mean (SEM)
values. The statistical significance of differences was assessed by Student’s
t test or one-way analysis of variance (ANOVA). Statistical analyses were
performed using Microsoft Excel or GraphPad Prism 9. All significance
levels are expressed as *P < 0.05, **P < 0.01, ***P < 0.001, and ****P <
0.0001.
RESULTS
Thrap3 colocalizes with R-loops, and Thrap3 depletion leads
to R-loop accumulation
Thrap3 is an RNA-binding protein related to the DNA damage
response through its involvement in RNA metabolism11. Therefore,
we hypothesized that Thrap3 can associate with RNA in R-loop
structures. Using a proximity ligation assay with the S9.6 antibody,
which can detect R-loops, and an anti-Thrap3 antibody, we
detected the colocalization of Thrap3 with R-loops in the nuclear
region; in addition, depletion of Thrap3 using siRNA decreased the
ligation signals in both cancer and normal (MEF) cells (Fig. 1a,
Supplementary Fig. 1a, b). In addition, a DNA-RNA immunopre-
cipitation assay with the S9.6 and anti-Thrap3 antibodies
confirmed the association between R-loops and Thrap3 in U2OS
cells (Fig. 1b). Next, we investigated whether Thrap3 regulates the
R-loop abundance. Immunofluorescence imaging showed that the
abundance of R-loops was significantly increased when Thrap3
Fig. 2 Thrap3 depletion inhibits replication and induces DSBs. a U2OS cells were transfected with scrambled (control) or Thrap3-targeted
(Thrap3) siRNA for 24 h. The cells were then subjected to a PLA to assess the physical closeness of PCNA and R-loops. Representative images
are presented. The scale bar represents 1 μm. b, c siRNA-transfected cells were transfected a second time with a plasmid expressing RNaseH1,
as indicated. EdU-Click labeling was performed, and EdU incorporation was visualized. b Representative images. The white arrows indicate
EdU-negative nuclei. c The Mean intensity and percentage of EdU-positive cells were measured from >30 cells. Mean ± SEM; n= 3; **P < 0.01,
***P < 0.001, ****P < 0.0001. The scale bar represents 2 μm. d siRNA-transfected cells were transfected a second time with a plasmid expressing
RNaseH1, as indicated. Cells were fixed and immunostained for γH2AX. (Left) representative images. (Right) the number of γH2AX foci per
nucleus after subtraction of nucleolar signals was determined from at least 30 nuclei. Mean ± SEM, ****P < 0.0001. The scale bar represents
2 μm. e siRNA-transfected cells were transfected a second time with a plasmid expressing RNaseH1, as indicated. The cells were fixed and
immunostained for 53BP1. (Left) representative images. (Right) the number of 53BP1 foci per nucleus after subtraction of nucleolar signals was
determined from at least 30 nuclei. Mean ± SEM; **P < 0.01, ****P < 0.0001. The scale bar represents 2 μm. f U2OS cells were transfected with
scrambled (Control) or Thrap3-targeted (Thrap3) siRNA for 24 h. Cells were trypsinized, and 1000 cells were seeded in 6-well plates. The cells
were allowed to proliferate for 12 days and were then fixed and stained with 10% methylene blue in 70% ethanol. The colonies were counted.
(Left) representative images. (Right) the numbers of stained cell colonies per well. Mean ± SEM, **P < 0.01. g U2OS cells were transfected with
scrambled (Control) or Thrap3-targeted (Thrap3) siRNA for 24 h. Cells were trypsinized, 104 cells were plated in 24-well plates, and the cell
confluence was monitored every 12 h using an IncuCyte FLR cell imaging microscope. Mean ± SEM; **P < 0.01, ***P < 0.001, ****P < 0.0001.
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expression was knocked down by siRNA (Fig. 1c) but decreased
when Thrap3 was overexpressed (Fig. 1d). Together, these findings
suggest that Thrap3 interacts with and modulates R-loops.
Thrap3 depletion inhibits DNA replication and induces
double-strand break (DSB) formation
Depletion of Thrap3 increases R-loop accumulation. Because PCNA
is abundant at the replication fork in transcription-replication
collision (TRC) regions within R-loops14,15, we analyzed PCNA
levels on R-loops when Thrap3 was depleted. PLA showed a
significant increase in PCNA levels on R-loops (Fig. 2a). Because an
unresolved R-loop causes DNA damage and promotes DNA strand
breaks1,6,7, EdU incorporation in U2OS cells was measured under
control and Thrap3 knockdown conditions to assess DNA
replication. Decreased expression of Thrap3 inhibited DNA
replication, and overexpression of RNaseH1, which is a ribonu-
clease responsible for R-loop resolution, restored the capacity for
replication (Fig. 2b, c). Next, knockdown of Thrap3 was found to
increase the numbers of γH2AX and 53BP1 foci, which are
representative markers of DSBs, per nucleus (Fig. 2d, e). Over-
expression of RNaseH1 reduced DNA double-strand breakage
induced by Thrap3 depletion. These data suggest that Thrap3
protects against replication stress and DSBs by preventing R-loop
accumulation. In addition, to determine whether Thrap3 depletion
is associated with cell proliferation, we performed a colony
formation assay (Fig. 2f) and IncuCyte cell imaging to monitor cell
confluence (Fig. 2g). Depletion of Thrap3 resulted in inhibition of
colony formation and cell proliferation. Thus, Thrap3 depletion
inhibits DNA replication, resulting in retarded cell proliferation.
Thrap3 binds to DDX5
Mass spectrometry was performed to identify Thrap3 interacting
proteins and determine the mechanisms by which Thrap3
regulates R-loop levels and genomic stability. Proteins with
significant expression changes of more than twofold upon
modulation of Thrap3 expression were identified, and these
proteins were then matched with the R-loop interactome dataset
(PRIDE: PXD002960). The intersection of the two protein groups
Fig. 3 Thrap3 binds to DDX5 and XRN2. a Process for classifying Thrap3 binding proteins. b U2OS cell lysates were immunoprecipitated with
normal IgG (IgG) or an anti-Thrap3 antibody (Thrap3). Precipitates and cell lysates were subjected to immunoblotting for Thrap3 and DDX5. c
U2OS cells were treated with 10 μM EPZ015666 (EPZ) for 48 h. Cells were then immunoprecipitated with an anti-Thrap3 antibody (Thrap3).
Precipitates and cell lysates were subjected to immunoblotting for DDX5, Thrap3 and MetR. d Schematic of DDX5 functional domains and
motifs. e U2OS cells were transfected with Flag/Myc-tagged DDX5 and DDX5-RK combined with HA-tagged Thrap3. The cells were then
immunoprecipitated with an anti-HA antibody (HA). Precipitates and cell lysates were subjected to immunoblotting for FLAG and HA.
H.J. Kang et al.
1606
Experimental & Molecular Medicine (2021) 53:1602 – 1611
contained only 29 proteins. Among these 29 proteins, we focused
on DDX5, which is known as an R-loop-regulating RNA helicase
and a key Thrap3 interacting protein (Fig. 3a). We first examined
the endogenous interaction between Thrap3 and DDX5 in U2OS
cells. Lysed cells were incubated with the anti-Thrap3 antibody
and control IgG, and DDX5 was coimmunoprecipitated with
Thrap3 (Fig. 3b). DDX5 resolves R-loops and prevents the
accumulation of R-loops by recruiting nucleases to methylated
arginine-guanine motifs by PRMT58,9. Therefore, we first checked
whether Thrap3 regulates DDX5 methylation and found no
difference in DDX5 methylation after Thrap3 depletion (Supple-
mentary Fig. 2a, b). Therefore, it was also confirmed that the
association between Thrap3 and DDX5 is altered by DDX5
methylation. U2OS cells were treated with 10 μM EPZ015666 for
48 h to inhibit PRMT5-mediated methylation. Inhibition of DDX5
arginine methylation also inhibited its protein interaction with
Thrap3 (Fig. 3c). To further confirm the effect of EPZ015666, wild-
type Flag/Myc-DDX5 and RK mutants were generated, in which
five arginine sequences known to be methylated by PRMT5 were
altered to lysine residues (Fig. 3d)8,9. The interaction between the
DDX5 RK mutant and Thrap3 was diminished following EPZ015666
treatment (Fig. 3e). These results indicate that Thrap3 physically
interacts with the RNA helicase DDX5.
Thrap3 is associated with XRN2 on R-loops, and XRN2 is a
downstream target of Thrap3
XRN2 is involved in R-loop resolution via its exonuclease
function and downstream proteins of methylated DDX5; there-
fore, it was determined whether Thrap3 also binds to XRN2.
Immunoprecipitation data demonstrated that Thrap3 endogen-
ously binds with XRN2 (Fig. 4a). To determine whether the
interaction between DDX5 and XRN2 is R-loop-dependent, we
tested the effect of RNaseH1 on this interaction. When RNaseH1
was overexpressed, protein binding between DDX5 and XRN2
Fig. 4 Thrap3 is associated with XRN2 on R-loops, and XRN2 is a downstream target of Thrap3. a U2OS cell lysates were
immunoprecipitated with normal IgG (IgG) or an anti-Thrap3 antibody (Thrap3). Precipitates and cell lysates were subjected to
immunoblotting for Thrap3 and XRN2. b U2OS cells were transfected with RNaseH1 overexpression plasmids for 24 h. Cell lysates were then
immunoprecipitated with an anti-DDX5 antibody (DDX5). Precipitates and cell lysates were subjected to immunoblotting for XRN2 and DDX5.
c U2OS cells were transfected with RNaseH1 overexpression plasmids for 24 h. Cell lysates were then immunoprecipitated with an anti-Thrap3
antibody (Thrap3). Precipitates and cell lysates were subjected to immunoblotting for XRN2, DDX5, and Thrap3. d U2OS cells were transfected
with scrambled (control) or Thrap3-targeted (Thrap3) siRNA for 24 h. Cell lysates were then immunoprecipitated with an anti-DDX5 antibody
(DDX5). Precipitates and cell lysates were subjected to immunoblotting for Thrap3, XRN2, and DDX5. e U2OS cells were transfected with
scrambled (control) or Thrap3-targeted (Thrap3) siRNA for 24 h, and DRIP was then performed. Precipitates were analyzed by immunoblotting
for XRN2 and DDX5. f U2OS cells were transfected with scrambled (control) or Thrap3-targeted (Thrap3) siRNA for 24 h. The cells were then
subjected to a PLA to assess the physical closeness of R-loops and XRN2. (Left) Representative images are shown. (Right) Percentages of PLA
signal-positive nuclei were calculated from at least 30 cells. Mean ± SEM, n= 3, *P < 0.05. The scale bar represents 1 μm.
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was weakened (Fig. 4b). Interestingly, XRN2 recruitment to
Thrap3 was also significantly decreased (Fig. 4c). Next, we
examined whether Thrap3 affects the association between
DDX5 and XRN2. Thrap3 siRNA- and control siRNA-transfected
U2OS cells were lysed and immunoprecipitated with the anti-
DDX5 antibody. The level of DDX5-interacting XRN2 was
reduced under Thrap3 depletion conditions (Fig. 4d).
We assessed the interactions of Thrap3 with the R-loop
resolution proteins DDX5 and XRN2 (Fig. 3a–e and Fig. 4a–d).
However, the mechanisms by which R-loop resolution is mediated
by Thrap3 are unknown. Given the result of each interaction
between Thrap3, DDX5, and XRN2, we hypothesized that Thrap3
may mediate the recruitment of these R-loop resolution proteins.
Therefore, a DRIP assay was applied under Thrap3 knockdown
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conditions, and Thrap3 depletion was found to cause a reduction
in XRN2 binding on R-loops, although DDX5 binding was
unchanged (Fig. 4e). In addition, Thrap3 knockdown cells showed
significantly low PLA signals for binding between the S9.6
antibody and XRN2 (Fig. 4f). These results suggest that Thrap3-
induced R-loop accumulation is partially caused by a decrease in
XRN2 recruitment.
Thrap3 is required for R-loop resolution in breast cancer
Next, the role of Thrap3 in R-loop resolution under pathophysio-
logical conditions was investigated. As observed in U2OS cells,
Thrap3 depletion reduced EdU-incorporation in MCF7 breast
adenocarcinoma cells, indicating decreased DNA replication (Fig.
5a). In addition, Thrap3 knockdown in MCF7 cells induced R-loop
accumulation in nuclei (Fig. 5b). Thrap3-mediated R-loop accu-
mulation induced γH2AX and 53BP1 localization in the nucleus,
and resolution of R-loops through overexpression of RNaseH1
alleviated DNA double-strand breakage caused by Thrap3 knock-
down (Fig. 5c). The growth of Thrap3 knockdown MCF7 breast
cancer cell lines was significantly inhibited, and RNaseH1
expression restored the cell proliferation capacity (Fig. 5d, e).
These data indicate that Thrap3 is required for R-loop resolution in
MCF7 cells.
DISCUSSION
R-loops have important physiological roles and have been
implicated in the pathogenesis of various diseases1,2,16. Although
the factors and cellular processes associated with R-loops have
been extensively studied, many aspects of R-loop biology and R-
loop-mediated genome instability remain unclear. This study
focused on the function of Thrap3 in R-loop-associated DNA
damage in cancer cells and identified Thrap3 as a novel regulator
of R-loop-associated DNA damage. Thrap3 is recruited to R-loop-
forming loci, and loss of Thrap3 increases R-loop accumulation
and DNA damage, thereby increasing the amount of replication
stress, demonstrating that Thrap3 plays an important role in
resolving R-loop-associated DNA damage in cancer cells. Thrap3 is
also required for the recruitment of XRN2 into R-loops for their
resolution. Similar results were obtained by knocking down PRMT5
or inhibiting DDX5 expression8. These findings provide new
insights into the molecular mechanisms underlying cellular DNA
damage and the repair response, as well as the novel functions of
Thrap3 in R-loop biology (Fig. 6).
RNA processing factors play various roles in the DNA damage
response17. They regulate mRNAs encoding DNA repair factors or
are involved in DNA repair by associating with DNA damage
response factors17. However, the mechanism of RNA processing
factor-dependent R-loop resolution remains unknown. Interest-
ingly, it has been reported that Thrap3 and DDX5 have common
binding proteins related to RNA processing factors, including
SRSF1 and TAF1518. Loss of SRSF1, a well-known splicing factor,
induces R-loop accumulation and genomic instability6,19. In
addition, TAF15 is recruited to DNA damage sites with other
R-loop suppressor proteins, including EWSF1, SAFA, and FUS, and
prevents R-loop accumulation20–22. Thus, there is a possibility that
Thrap3 has various downstream targets for R-loop removal via its
interaction with DDX5. However, more precise mechanistic studies
on Thrap3-mediated R-loop resolution are needed. In addition,
Thrap3 has another binding candidate, SRSF6 (list of top-ranked
Thrap3 binding proteins, Fig. 3a). SRSF6 regulates constitutive
splicing and modulates alternative splice site selection23. Although
SRSF6 has not been characterized as a DNA damage- or R-loop-
mediated factor, Thrap3 might function in genomic instability with
SRSF6 through a physical interaction.
Proteins that regulate gene transcription also have functions in
other DNA processes, such as DNA replication and repair24–29. For
example, RNA m6A (methylation of an A base), which is important
for many RNA metabolic processes, is highly enriched at sites of
UV irradiation-induced DNA damage for DNA polymerase kappa
(POLK) recruitment30. In addition, TonEBP, a pleiotropic transcrip-
tion factor, plays a role in the DNA damage response through
interaction with various proteins related to PCNA polyubiquitina-
tion or m6A RNA methylation27,28. According to our unpublished
data, Thrap3 binds to TonEBP and induces PCNA ubiquitination
under conditions of DNA damage. Consistent with this idea and
our preliminary data, the RNA processing factor Thrap3 might
participate in the DNA damage response by regulating RNA
modification in cooperation with various types of binding proteins
(TonEBP, RNaseH1, PCNA, etc.).
DDX5 has been studied for its function in cellular RNA
processing31. Its role in transcription, as suggested by studies in
Drosophila and yeast DDX5 homologs, is to activate RNA release
from chromatin32,33. DDX5 also plays a role in transcription
Fig. 5 Thrap3 is required for R-loop resolution in breast cancer. a MCF-7 cells were transfected as indicated and were then subjected to
EdU-Click labeling analysis. The scale bar represents 5 μm. (Left) representative images; the white arrows indicate EdU-negative nuclei; (right)
the percentage of EdU-positive cells was measured from >30 cells. Mean ± SEM, n= 3, **P < 0.01. b Cells were transfected with scrambled
siRNA (control) or Thrap3-targeted (Thrap3) siRNA for 48 h. Cells were fixed and immunostained for S9.6 and nucleolin. (Left) representative
images; (right) the number of S9.6 foci per nucleus after subtraction of nucleolar signals was determined from at least 30 nuclei. Mean ± SEM,
**P < 0.01. The scale bar represents 0.5 μm. c siRNA-transfected cells were transfected a second time with a plasmid expressing RNaseH1, as
indicated. Cells were fixed and immunostained for γH2AX or 53BP1. (Top) representative images; (bottom) percentages of γH2AX- and 53BP1-
positive nuclei were calculated from at least 30 cells. Mean ± SEM, n= 3, **P < 0.01, ****P < 0.0001. The scale bar represents 1 μm. dMCF-7 cells
expressing scrambled (control) or Thrap3 (shThrap3) shRNA were analyzed by immunoblotting for Thrap3, DDX5, and XRN2. e MCF-7 cells
expressing scrambled shRNA (control), Thrap3 shRNA #1 (shThrap3 #1), or Thrap3 shRNA #2 (shThrap3 #2) were transfected with RNaseH1
overexpression plasmids. Cells were then analyzed using an IncuCyte assay to confirm cell growth. (Top) the relative cell confluence was
measured daily for a 90 h period. Mean ± SEM; n= 3; *P < 0.05, **P < 0.01. #P < 0.05, comparison between vector- and RNaseH1-transfected
cells. (Bottom) Representative cell confluency at 90 h after seeding. Mean ± SEM; n= 3; *P < 0.05, **P < 0.01, ##P < 0.01, comparison to control
cells. $P < 0.05, comparison between vector- and RNaseH1-transfected cells.
Fig. 6 Model for the function of Thrap3 in R-loop resolution.
Working hypothesis of the function of Thrap3 in R-loop resolution.
The RNA-binding protein Thrap3 localizes at R-loops. In addition,
PRMT5 induces methylation of RG/RGG motifs in DDX5 at R-loops.
Thrap3 binds to methylated DDX5, and this binding is followed by
XRN2 recruitment. XRN2 resolves R-loops through its exonuclease
activity.
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initiation through the resolution of R-loop enrichment in
promoters and transcription start site (TSS) regions with a high
GC content34. However, how DDX5 is recruited to these sites is not
known. Our data suggest that Thrap3 is associated with DDX5 for
R-loop resolution and that overexpression of RNaseH1 restored
the effect of Thrap3 depletion on cell proliferation; therefore, it is
possible that Thrap3 regulates DDX5 recruitment to promoter
and/or TSS regions and DNA damage lesions. It has been reported
that treatment of human breast cancer cells with 17β-estradiol
(E2) dramatically increases the accumulation of R-loops, particu-
larly in regions of the genome containing estrogen-induced
genes35. Interestingly, estrogen receptor α (ERα) specifically
interacts with Thrap3 under conditions of E2 exposure36. Because
E2-dependent R-loop generation and rearrangement in breast
cancer cells are mainly enriched at E2-responsive genomic loci, it
is possible that Thrap3 might be localized to E2-responsive
genomic loci with ERα and that this localization is followed by
DDX5 recruitment for precise removal of cotranscriptional R-loops
in breast cancer cells, which is critical for cancer progression.
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